Detalhe da pesquisa
1.
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.
Blood
; 142(8): 700-710, 2023 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319437
2.
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.
Bone Marrow Transplant
; 59(5): 680-687, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383714
3.
The Adverse Event Landscape of Stem Cell Transplant: Evidence for aGVHD Driving Early Transplant Associated Toxicities.
Transplant Cell Ther
; 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38583802
4.
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease.
Sci Transl Med
; 13(576)2021 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33441422
5.
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.
J Clin Oncol
; 39(17): 1865-1877, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33449816
6.
Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies.
Bone Marrow Transplant
; 58(11): 1264-1266, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580397
7.
Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.
Bone Marrow Transplant
; 58(11): 1260-1263, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580396
8.
Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis.
Blood Adv
; 7(16): 4395-4399, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285800
9.
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.
Blood Adv
; 6(3): 746-749, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34753172